See Also:
HWCI Research Associate Program
Submissions from 2026
Proton Therapy for Head and Neck Adenoid Cystic Carcinoma: A Multi-institutional Review, Noah Kalman
Proton Therapy for Head and Neck Adenoid Cystic Carcinoma: A Multi-institutional Review, Noah Kalman
Real-world avatrombopag use for immune thrombocytopenia in the United States: the REAL-AVA 2.0 multisite chart review study, Srikanth Nagalla
Real-World Outcomes of Elacestrant in ER+, HER2-, ESR1-Mutant Metastatic Breast Cancer, Reshma Mahtani
Real-world treatment patterns and sequencing in patients with advanced / metastatic HR+/HER2- breast cancer in Europe and the United States, Reshma Mahtani
Regimen-Related Oral Mucosal Injury: Pathobiology, Clinical Consequences and Rationale for Intervention Across Cancer Treatment Modalities, Alessandro Villa
Regimen-Related Oral Mucosal Injury: Pathobiology, Clinical Consequences and Rationale for Intervention Across Cancer Treatment Modalities, Alessandro Villa
Reply to: Blood-Brain Barrier Heterogeneity in NRG BN007: Implications for Immunotherapy Delivery, Minesh Mehta
Safety and Efficacy of Irreversible Electroporation in the Treatment of Lesions Near or Involving Gastrointestinal Structures, Govindarajan Narayanan and Nicole Gentile
Safety and Efficacy of LP-10 Liposomal Tacrolimus in Oral Lichen Planus: A Multicenter Phase 2 Trial, Alessandro Villa
Safety and Efficacy of LP-10 Liposomal Tacrolimus in Oral Lichen Planus: A Multicenter Phase 2 Trial, Alessandro Villa
Safety of immune checkpoint modulators beyond PD-1/PD-L1 and CTLA-4 in solid tumors: a meta-analysis, Manmeet Ahluwalia and Sarbajit Mukherjee
Sociodemographic Factors and Treatment Patterns Associated with Overall Survival in Splenic Marginal Zone Lymphoma: A Nationwide Retrospective Cohort Study (2000-2022), Mohammad Arfat Ganiyani
Study of brentuximab vedotin combination treatment in people with early-stage Hodgkin lymphoma: a plain language summary, Yuliya Linhares
Study of brentuximab vedotin combination treatment in people with early-stage Hodgkin lymphoma: a plain language summary, Yuliya Linhares
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0, Bruna Pellini
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0, Bruna Pellini
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.1, Bruna Pellini
The Role of Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Carcinoma in the Era of Emerging Systemic Therapy: A Retrospective Cohort Study, Mohammad Arfat Ganiyani, Arjun Pon Avudaiappan, Mohamed Javid Raja Iyub, Murugesan Manoharan, and Rohan Garje
Three-Arm Versus Four-Arm Configurations in Robot-Assisted Partial Nephrectomy: A Systematic Review and Meta-Analysis, Mohamed Javid Raja Iyub, Pushan Prabhakar, Deerush Kannan Sakthivel, Manuel Ozambela, and Murugesan Manoharan
Time Course and Determinants of Acute Dysgeusia in Patients Receiving Head and Neck Radiation Therapy, Sreenija Yarlagadda, Arun Maharaj, Andrea Gonzalez, NaimaSajoni Guerra, Dylan Paterniti-Ruscin, Elysse Castro-Hall, Lorein Gonzalez, Muni Rubens, Noah Kalman, and Adeel Kaiser
TP53 mutation is associated with improved disease control in patients with advanced RAS wild-type colorectal adenocarcinoma treated with cetuximab and pembrolizumab, Sarbajit Mukherjee
TP53 mutation is associated with improved disease control in patients with advanced RAS wild-type colorectal adenocarcinoma treated with cetuximab and pembrolizumab, Sarbajit Mukherjee